Filing Details
- Accession Number:
- 0001140361-11-023854
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-29 11:01:56
- Reporting Period:
- 2011-04-28
- Filing Date:
- 2011-04-29
- Accepted Time:
- 2011-04-29 11:01:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377232 | Phd J Michael Williams | One Idexx Drive Westbrook ME 04092 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-04-28 | 7,000 | $28.66 | 16,154 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-28 | 3,844 | $38.34 | 19,998 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-04-28 | 1,678 | $38.34 | 21,676 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-04-28 | 12,522 | $80.90 | 9,154 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-04-28 | 7,000 | $0.00 | 7,000 | $28.66 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-04-28 | 3,844 | $0.00 | 3,844 | $38.34 |
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-04-28 | 1,678 | $0.00 | 1,678 | $38.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,806 | 2015-02-02 | No | 4 | M | Direct | |
| 0 | 2013-02-13 | No | 4 | M | Direct | |
| 0 | 2013-02-13 | No | 4 | M | Direct |
Footnotes
- Includes 89 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/31/2011.
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $80.83 to $80.95, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of options to buy shares of common stock becomes exercisable as to 2,720 shares on 02/03/2006, 02/03/2007 and 2/3/2008, and the remaining 1,646 shares on 02/03/2009.
- Grant of options to buy shares of common stock becomes exercisable as to 1,106 shares on 02/14/2007, 1,104 shares on 02/14/2008 and 02/14/2009, and the remaining 530 shares on 02/14/2010.
- Grant of options to buy shares of common stock becomes exercisable as to 574 shares on 02/14/2010 and the remaining 1,104 shares on 02/14/2011.
Billionaire Hedge Funds
